GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Total Debt per Share

Oncolys BioPharma (TSE:4588) Total Debt per Share : 円13.88 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Total Debt per Share?

円13.88 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Oncolys BioPharma's Total Debt Per Share for the quarter that ended in Mar. 2024 was 円13.88.

Oncolys BioPharma Total Debt per Share Historical Data

The historical data trend for Oncolys BioPharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Total Debt per Share Chart

Oncolys BioPharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.90 35.90 29.04 22.73 16.06

Oncolys BioPharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.75 25.35 17.77 16.06 13.88

Oncolys BioPharma Total Debt per Share Calculation

Oncolys BioPharma's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(179.83+135.34)/19.63
=16.06

Oncolys BioPharma's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(156.23+132.06)/20.78
=13.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncolys BioPharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Oncolys BioPharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolys BioPharma (TSE:4588) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Total Debt per Share
Comparable Companies
TSE:4598 TSE:4888 TSE:7776 TSE:4891 TSE:2370 TSE:3750 TSE:4896 TSE:4594 TSE:4572 TSE:4593 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
Website
http://www.oncolys.com
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma (TSE:4588) Headlines

No Headlines